BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 35277173)

  • 1. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease.
    Pilat D; Paumier JM; García-González L; Louis L; Stephan D; Manrique C; Khrestchatisky M; Di Pasquale E; Baranger K; Rivera S
    J Neuroinflammation; 2022 Mar; 19(1):65. PubMed ID: 35277173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease.
    Baranger K; Marchalant Y; Bonnet AE; Crouzin N; Carrete A; Paumier JM; Py NA; Bernard A; Bauer C; Charrat E; Moschke K; Seiki M; Vignes M; Lichtenthaler SF; Checler F; Khrestchatisky M; Rivera S
    Cell Mol Life Sci; 2016 Jan; 73(1):217-36. PubMed ID: 26202697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MT5-MMP Promotes Alzheimer's Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking
    Baranger K; Bonnet AE; Girard SD; Paumier JM; García-González L; Elmanaa W; Bernard A; Charrat E; Stephan D; Bauer C; Moschke K; Lichtenthaler SF; Roman FS; Checler F; Khrestchatisky M; Rivera S
    Front Mol Neurosci; 2016; 9():163. PubMed ID: 28119565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MT5-MMP controls APP and β-CTF/C99 metabolism through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease.
    García-González L; Paumier JM; Louis L; Pilat D; Bernard A; Stephan D; Jullien N; Checler F; Nivet E; Khrestchatisky M; Baranger K; Rivera S
    FASEB J; 2021 Jul; 35(7):e21727. PubMed ID: 34117802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes.
    Arnst N; Belio-Mairal P; García-González L; Arnaud L; Greetham L; Nivet E; Rivera S; Dityatev A
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MT5-MMP, just a new APP processing proteinase in Alzheimer's disease?
    Baranger K; Khrestchatisky M; Rivera S
    J Neuroinflammation; 2016 Jun; 13(1):167. PubMed ID: 27349644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
    Lantz MJ; Roberts AM; Delgado DD; Nichols RA
    J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
    Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
    Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
    Fragkouli A; Tsilibary EC; Tzinia AK
    Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
    Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R
    PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
    Devi L; Ohno M
    Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease.
    Couturier J; Stancu IC; Schakman O; Pierrot N; Huaux F; Kienlen-Campard P; Dewachter I; Octave JN
    J Neuroinflammation; 2016 Jan; 13():20. PubMed ID: 26818951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease.
    Davis N; Mota BC; Stead L; Palmer EOC; Lombardero L; Rodríguez-Puertas R; de Paola V; Barnes SJ; Sastre M
    J Neuroinflammation; 2021 Mar; 18(1):73. PubMed ID: 33731156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCSK6 exacerbates Alzheimer's disease pathogenesis by promoting MT5-MMP maturation.
    Xu M; Li J; Xia L; Du Y; Wu B; Shi X; Tian N; Pang Y; Yi L; Chen M; Song W; Dong Z
    Exp Neurol; 2024 Apr; 374():114688. PubMed ID: 38216110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.
    Devi L; Ohno M
    Neurobiol Dis; 2012 Jan; 45(1):417-24. PubMed ID: 21933711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice.
    Ou-Yang MH; Van Nostrand WE
    J Neuroinflammation; 2013 Nov; 10():134. PubMed ID: 24188129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CERT
    Crivelli SM; Luo Q; Stevens JAA; Giovagnoni C; van Kruining D; Bode G; den Hoedt S; Hobo B; Scheithauer AL; Walter J; Mulder MT; Exley C; Mold M; Mielke MM; De Vries HE; Wouters K; van den Hove DLA; Berkes D; Ledesma MD; Verhaagen J; Losen M; Bieberich E; Martinez-Martinez P
    Alzheimers Res Ther; 2021 Feb; 13(1):45. PubMed ID: 33597019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis.
    Zhao J; O'Connor T; Vassar R
    J Neuroinflammation; 2011 Nov; 8():150. PubMed ID: 22047170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection.
    Iram T; Trudler D; Kain D; Kanner S; Galron R; Vassar R; Barzilai A; Blinder P; Fishelson Z; Frenkel D
    Neurobiol Dis; 2016 Dec; 96():84-94. PubMed ID: 27544484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages.
    Devi L; Ohno M
    Neuroscience; 2015 Oct; 307():128-37. PubMed ID: 26314636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.